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Abstract 
 
Different COVID-19 testing approaches have been implemented among Italian regions, 
reflected in heterogeneous testing rates. We analysed the number COVID-19-related deaths in 
relation to the number of tests performed among the most hit Italian regions. We showed that 
regions with the highest number of tests performed (Veneto and Toscana) had the lowest 30-
day crude mortality rate per 100,000 inhabitants. In addition, an inverse association between 
crude mortality rates and tests performed (mortality rate ratio for unit increase in tests per 
1,000 inhabitants: 0.92; 95% CI 0.89-0.94) was observed. Early identification and isolation of 
active cases (including asymptomatic or mildly symptomatic subjects) could have had an 
important effect in lowering COVID-19 mortality.  
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Introduction: 
 
The first locally transmitted case of SARS-CoV-2 in Italy was detected on February 21, 2020. 
The increasing number of cases, forced the Italian government to introduce specific measures 
to restrict social contact at the beginning of March1,2. These measures were further tightened 
on March 22, 2020, when the Italian government declared a total lockdown, only allowing 
essential activities3.  As of May 6, 2020, Italy was the most affected European country in terms 
of COVID-19-related deaths, with more than 29,000 fatal events recorded. The crude COVID-
19 case-fatality ratio (CFR) in Italy was one of the highest in the world (~14%)4. One of the 
reasons might be that initial Italian testing coverage has been lower than other European 
countries5; a low coverage of the population at risk implies a lower chance to find positive 
asymptomatic individuals, thus underestimating the total number of cases, yielding an 
increased CFR. However, given that governance of the Italian Health System is decentralised, 
different COVID-19 testing approaches have been adopted by Italian regions, reflected in the 
extremely variable testing rates6. 
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Rationale: 
Testing subjects with diagnostic tests could facilitate early identification of active cases 
(including asymptomatic or mildly symptomatic subjects) and could have an effect in 
lowering COVID-19 mortality, by isolating cases that would otherwise continue to spread the 
virus in the susceptible and vulnerable population. Heterogeneity in testing approaches 
within the same country offers the opportunity to study whether different testing strategies 
had an effect in lowering the COVID-19 mortality, since heterogeneity in other potential 
confounders (quality and timing of restrictive measures, or population age-structure) is 
limited within the same country7.  
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Methods: 
Since the number of confirmed cases is affected by testing coverage, we focused on the 
number COVID-19 related deaths, which are less likely to be affected by testing approaches, in 
the seven most affected Italian regions as of May 6, 2020. First, cumulative mortality rate 
curve per 100,000 inhabitants was plotted for each region, starting from the day with at least 
five cumulative COVID-19 deaths (considered as “day 1”) up to 30 days (considered as “day 
30”). We then computed crude mortality rates (CMRs) at day 30 with corresponding 95% 
confidence interval (exact Poisson method). Finally, we fitted a multilevel Poisson regression 
to the cumulative number of COVID-19-related deaths occurred in the 30 days, using the 
population as offset and introducing a region-specific random effect.  The model was applied 
to study the mortality rates in relation to the cumulative number of tests performed in each 
region over the 30-day observation period. Tests performed were expressed both as the 
number of tests per identified case and as number of tests per 1,000 inhabitants. Regression 
analysis was adjusted for the proportion of inhabitants over 65 years of age. All data were 
obtained from the Italian Civil Protection website6 and analysis was performed with R (R 
Foundation For Statistical Computing, Vienna, Austria). 
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Results: 
Figure 1 reports cumulative mortality rate curves for the seven Italian regions. Veneto and 
Toscana experienced by far lower mortality rates compared to other regions (Table 1). 
Interestingly, Veneto and Toscana are the two regions with the highest number of tests 
performed (Table 1). Considering regions altogether, we observed an inverse association 
between crude mortality rates and tests performed (Mortality Rate Ratio (MRR) for unit 
increase in tests per identified case: 0.87, 95% CI 0.84-0.90; MRR for unit increase in tests per 
1,000 inhabitants: 0.92; 95% CI 0.89-0.94). 
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Discussion: 
Our study shows that Italian regions experienced different COVID-19 mortality rates. This 
may be only partially explained by differences in the population age-structure (the proportion 
of over 65 years old being 22.9% in Veneto and 22.5% in Lombardia, as an example) or in 
COVID-19-related deaths reporting. COVID-19 mortality rates, instead, result associated with 
different testing approaches adopted by the investigated Italian regions. In particular, our 
results suggest that higher testing rates were associated with lower crude mortality rates. 
Early identification of active cases (including asymptomatic or mildly symptomatic subjects) 
might have had an effect in lowering COVID-19 mortality, by isolating cases that would 
otherwise continue to spread the virus in the susceptible population and possibly preventing 
overwhelm of local healthcare systems. Increasing testing coverage and active tracing of 
contacts may play a relevant role in limiting public health impact of the COVID-19 outbreak, 
by significantly reducing deaths in the population.  
Limitations 
The present results must be interpreted with caution, given that the study is based on 
aggregated regional data. As most of ecological studies, systematic differences between 
regions in exposure (tests performed) and outcome (COVID-19 related deaths) measurements 
are possible. However, since this study was performed within the same country, strong 
heterogeneity in these measurements is unlikely. In addition, comparing data between 
regions from the same country should have limited the heterogeneity in other potential 
confounders (e.g. timing and quality of restrictive measures).  
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Conclusion 
The present analysis on aggregate regional Italian data suggests that higher COVID-19 testing 
rates were associated with lower mortality during the first month of the outbreak. These 
results prompt urgent studies investigating the impact that preventive strategies, including 
the extent of testing coverage, may exert in terms of reducing COVID-19 mortality, both in 
high- and low-transmission settings.   
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Figure Legends 
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Tables 
Table 1. COVID-19 incidence rates, COVID-19 mortality rates and tests performed in 
different Italian regions in the 30 days after the fifth COVID-19 related deaths. 
 
Region 




 Incidence Rates  





at Day 30 
 (per 100,000 
inhabitants)  
Mortality Rate 




at Day 30 
  
Tests per 1,000 
inhabitants  
at Day 30 
 
Veneto 04-Mar 206.1 10.8 Ref 11.9 24.5 
Toscana 12-Mar 180.4 12.2 1.12 (0.99-1.27) 10.7 19.3 
Piemonte 07-Mar 283.8 26.8 2.47 (2.23-2.74) 3.1 8.8 
Emilia Romagna 01-Mar 315.6 32.3 2.98 (2.70-3.30) 3.8 11.4 
Liguria 08-Mar 293.4 38.4 3.54 (3.22-4.08) 3.7 10.0 
Marche 07-Mar 292.7 39.3 3.62 (3.22,4.08) 3.4 10.2 
Lombardia 24-Feb 305.2 41.5 3.83 (3.50-4.20) 2.5 7.6 
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